Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01058798).
References
- Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer-recent advances and future directions. Nature Reviews Endocrinology. 2018;14:670-683. https://doi.org/10.1038/s41574-018-0080-7
- Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Annals of Surgery. 2007;246:375-381. https://doi.org/10.1097/SLA.0b013e31814697d9
- Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer. Annals of Surgical Oncology. 2005;12:81-89. https://doi.org/10.1007/s10434-004-1165-1
- Bilimoria KY, Bentrem DJ, Linn JG, Freel A, Yeh JJ, Stewart AK, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142:906-913. https://doi.org/10.1016/j.surg.2007.09.002
- Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214. https://doi.org/10.1089/thy.2009.0110
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1-133. https://doi.org/10.1089/thy.2015.0020
- Kim BW, Yousman W, Wong WX, Cheng C, McAninch EA. Less is more: Comparing the 2015 and 2009 american thyroid association guidelines for thyroid nodules and cancer. Thyroid. 2016;26:759-764. https://doi.org/10.1089/thy.2016.0068
- Leong D, Ng K, Nguyen H, Ryan S. Preoperative ultrasound characteristics in determining the likelihood of cytologically confirmed (Bethesda VI), 1-4 cm papillary thyroid tumours requiring completion thyroidectomy. Asian Journal of Surgery. In press 2021.
- Duenas JP, Duque CS, Cristancho L, Mendez M. Completion thyroidectomy: Is timing important for transcervical and remote access approaches? World Journal of Otorhinolaryngology-Head and Neck Surgery. 2020;6:165-170. https://doi.org/10.1016/j.wjorl.2020.02.006
- Stefanova DI, Bose A, Ullmann TM, Limberg JN, Finnerty BM, Zarnegar R, et al. Does the ATA risk stratification apply to patients with papillary thyroid microcarcinoma? World journal of surgery. 2020;44:452-460. https://doi.org/10.1007/s00268-019-05215-4
- Vargas-Pinto S, Arenas MAR. Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: A systematic review. Journal of Surgical Research. 2019;242:244-251. https://doi.org/10.1016/j.jss.2019.04.036
- Ritter A, Mizrachi A, Bachar G, Vainer I, Shimon I, Hirsch D, et al. Detecting recurrence following lobectomy for thyroid cancer: Role of thyroglobulin and thyroglobulin antibodies. The Journal of Clinical Endocrinology & Metabolism. 2020;105:e2145-e2151. https://doi.org/10.1210/clinem/dgaa152
- Nicholson KJ, Teng CY, McCoy KL, Carty SE, Yip L. Completion thyroidectomy: A risky undertaking? The American Journal of Surgery. 2019;218:695-699. https://doi.org/10.1016/j.amjsurg.2019.07.014
- Saleem RB, Saleem MB, Saleem NB. Impact of completion thyroidectomy timing on post-operative complications: a systematic review and meta-analysis. Gland Surgery. 2018;7:458-465. https://doi.org/10.21037/gs.2018.09.03
- Gulcelik MA, Dogan L, Akgul GG, Guven EH, Gulcelik NE. Completion thyroidectomy: Safer than thought. Oncology research and treatment. 2018;41:386-390. https://doi.org/10.1159/000487083
- Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, et al. Extrathyroidal extension: does strap muscle invasion alone influence recurrence and survival in patients with differentiated thyroid cancer? Annals of Surgical Oncology. 2018;25:3380-3388. https://doi.org/10.1245/s10434-018-6563-x
- Zhang L, Liu J, Wang P, Xue S, Li J, Chen G. Impact of gross strap muscle invasion on outcome of differentiated thyroid cancer: Systematic review and meta-analysis. Frontiers in Oncology. 2020;10:1687. https://doi.org/10.3389/fonc.2020.01687
- Danilovic DL, Castroneves LA, Suemoto CK, Elias LO, Soares IC, Camargo RY, et al. Is there a difference between minimal and gross extension into the strap muscles for the risk of recurrence in papillary thyroid carcinomas? Thyroid. 2020;30:1008-1016. https://doi.org/10.1089/thy.2019.0753
- Amin SN, Shinn JR, Naguib MM, Netterville JL, Rohde SL. Risk factors and outcomes of postoperative recurrent well-differentiated thyroid cancer: A single institution's 15-year experience. Otolaryngology-Head and Neck Surgery. 2020;162:469-475. https://doi.org/10.1177/0194599820904923
- Lee J, Song Y, Soh EY. Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World Journal of Surgery. 2014;38:858-862. https://doi.org/10.1007/s00268-013-2345-6